BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9304339)

  • 1. [The transfer of antibacterial resistance to recipients highly sensitive to glanders].
    Diadishchev NR; Vorob'eva AA; Zakharov SB
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):81-4. PubMed ID: 9304339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pathomorphology and pathogenesis of glanders in laboratory animals].
    Diadishchev NR; Vorob'ev AA; Zakharov SB
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):60-4. PubMed ID: 9245146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
    Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
    Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glanders: off to the races with Burkholderia mallei.
    Whitlock GC; Estes DM; Torres AG
    FEMS Microbiol Lett; 2007 Dec; 277(2):115-22. PubMed ID: 18031330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hamster model of intraperitoneal Burkholderia mallei (glanders).
    Fritz DL; Vogel P; Brown DR; Waag DM
    Vet Pathol; 1999 Jul; 36(4):276-91. PubMed ID: 10421094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomonas pseudomallei and Pseudomonas mallei--capsule-forming bacteria].
    Popov SF; Kurilov VIa; Iakovlev AT
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):32-6. PubMed ID: 8525729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice.
    Bozue JA; Chaudhury S; Amemiya K; Chua J; Cote CK; Toothman RG; Dankmeyer JL; Klimko CP; Wilhelmsen CL; Raymond JW; Zavaljevski N; Reifman J; Wallqvist A
    Front Cell Infect Microbiol; 2016; 6():21. PubMed ID: 26955620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of the causative agents of glanders and melioidosis by polymerase chain reaction].
    Tkachenko GA; Antonov VA; Zamaraev VS; Iliukhin VI
    Mol Gen Mikrobiol Virusol; 2003; (3):18-22. PubMed ID: 12966921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
    Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study on chemotherapy of acute glanders].
    Iliukhin VI; Rotov KA; Senina TV; Snatenkov EA; Tikhonov SN; Plekhanova NG; Kulikova AS; Shubnikova EV; Korol' EV; Nekhezina MO
    Antibiot Khimioter; 2012; 57(11-12):11-5. PubMed ID: 23700931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
    Galyov EE; Brett PJ; DeShazer D
    Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders.
    Zimmerman SM; Long ME; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Vet Pathol; 2018 Mar; 55(2):258-267. PubMed ID: 29145795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the infectious process in animals susceptible and resistant to glanders].
    Ferster LN; Kurilov VIa
    Arkh Patol; 1982; 44(11):24-30. PubMed ID: 7159234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of Pseudomonas mallei to tetracyclines and their effectiveness in experimental glanders].
    Batmanov VP
    Antibiot Khimioter; 1994 May; 39(5):33-7. PubMed ID: 7857158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type VI secretion is a major virulence determinant in Burkholderia mallei.
    Schell MA; Ulrich RL; Ribot WJ; Brueggemann EE; Hines HB; Chen D; Lipscomb L; Kim HS; Mrázek J; Nierman WC; Deshazer D
    Mol Microbiol; 2007 Jun; 64(6):1466-85. PubMed ID: 17555434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cellular immune response and innate immune signaling in human and nonhuman primate primary mononuclear cells exposed to Burkholderia mallei.
    Alam S; Amemiya K; Bernhards RC; Ulrich RG; Waag DM; Saikh KU
    Microb Pathog; 2015 Jan; 78():20-8. PubMed ID: 25450887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative experimental subcutaneous glanders and melioidosis in the common marmoset (Callithrix jacchus).
    Nelson M; Salguero FJ; Dean RE; Ngugi SA; Smither SJ; Atkins TP; Lever MS
    Int J Exp Pathol; 2014 Dec; 95(6):378-91. PubMed ID: 25477002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A real-time loop mediated isothermal amplification assay for molecular detection of Burkholderia mallei, the aetiological agent of a zoonotic and re-emerging disease glanders.
    Saxena A; Pal V; Tripathi NK; Goel AK
    Acta Trop; 2019 Jun; 194():189-194. PubMed ID: 30958991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of experimental equine glanders.
    Lopez J; Copps J; Wilhelmsen C; Moore R; Kubay J; St-Jacques M; Halayko S; Kranendonk C; Toback S; DeShazer D; Fritz DL; Tom M; Woods DE
    Microbes Infect; 2003 Oct; 5(12):1125-31. PubMed ID: 14554254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.